This study evaluated the possibility of inoculation and reinoculation with a trypanosomatid isolated from bats that is morphologically, biologically and molecularly similar to Trypanosoma cruzi, to protect against infection by virulent strains. Non-isogenic mice were divided into 24 groups that received from zero to three inoculations of Trypanosoma cruzi-like strain RM1, in the presence or absence of Freund's adjuvant, and were challenged with the VIC or JG strains of Trypanosoma cruzi. Parasitemia and survival were monitored and animals were sacrificed for histopathological analysis. Animals immunized with Trypanosoma cruzi-like strain RM1 presented decreased parasitemia, independently of the number of inoculations or the presence of adjuvant. In spite of this reduction, these animals did not present any protection against histopathological lesions. Severe eosinophilic infiltrate was observed and was correlated with the number of inoculations of Trypanosoma cruzi-like strain RM1. These findings suggest that prior inoculation with this strain did not protect against infection but, rather, aggravated the tissue inflammatory process.
, eight million people are currently infected with Trypanosoma cruzi in Latin America. Various measures have been proposed for effective control over Chagas disease, such as vector combat, housing improvement, prevention of transfusional transmission, animal reservoir control and research aimed towards obtaining an effective vaccine 16 .
Some of these investigations have involved cross-protection mechanisms using strains isolated from human cases 13 28 , trypanosomatid strains isolated from different reservoirs 7 9 31 36 and, more recently, DNA vaccines or recombinant proteins 14 35 . Heterologous immunization has been important due to associations between similar antigens from different trypanosomatids, in comparison with Trypanosoma cruzi, and their absence of pathogenicity for the vertebrate host. Several organisms have already been used in experimental models, like Leptomonas pessoai 36 , Phytomonas serpens 9 31 and Trypanosoma rangeli 7 , demonstrating partial protection. Nonetheless, the high variety of trypanosomatids circulating in animal reservoirs is still unknown. In many cases, the morphological but not biological characteristics of these trypanosomes coincide with what is obtained from Trypanosoma cruzi strains in human cases, which leads to classification of these species as Trypanosoma cruzi-like. In some previous studies, cross-protection assays were performed by using trypanosomatids isolated from bats against virulent strains of Trypanosoma cruzi 2 18 . In spite of the decreased parasitemia and increased survival among immunized animals, the parasites isolated in those cases were also able to infect mice, thus suggesting that these trypanosomes could be a particular strain of Trypanosoma cruzi.
In a recent study by Bento 8 at the Federal University of the Triângulo Mineiro (UFTM), a trypanosome strain was isolated from the bat Phyllostomus hastatus that is morphologically, biologically and molecularly similar to Trypanosoma cruzi but was unable to infect mice and was named Trypanosoma cruzi-like strain RM1. From this, a pilot study on experimental cross-protection was developed against a highly virulent strain of Trypanosoma cruzi (VIC strain), and the results showed significantly decreased parasitemia and increased survival among the animals inoculated with this strain (unpublished data).
By means of parasitological and histopathological analysis, in the present study we evaluated the induction of cross-protection by Trypanosoma cruzi-like strain RM1 that had previously been inoculated into mice, after challenging with different Trypanosoma cruzi strains.
MATERIAL AND METHODS
For this study, 236 non-isogenic Swiss mice were divided into 24 groups that received from zero to three inoculations of Trypanosoma cruzi-like strain RM1, in the presence or absence of Freund's adjuvant. These were then challenged with the VIC or JG strains of Trypanosoma cruzi or maintained as uninfected controls. Thus, the experimental model groups covered all the studied variables ( Table 1) .
The Trypanosoma cruzi-like strain RM1 was maintained in liver infusion tryptose medium (LIT) 12 and, for inoculations, the parasites were washed in saline and counted in a Neubauer chamber for volume correction to 3.0×10 6 parasites/0.1 ml, inoculated intraperitoneally in the mice. In the presence of adjuvant, an emulsion with saline was prepared, using the same volume, and subcutaneously inoculated. For the prime immunization of the animals, complete Freund's adjuvant was used, and this was replaced by incomplete adjuvant in subsequent inoculations. The challenge was undertaken using the VIC 32 and JG strains of Trypanosoma cruzi (E Lages-Silva: personal communication, 1995). The parasitemia peaks were synchronized so that infections were performed for both strains on the same day. The inoculum was prepared using the method described by Brener 10 , using 25 10 3 trypomastigotes for the VIC strain and 35 10 3 for the JG strain. The inoculations respected a 30-day interval and, between these, two animals in each group inoculated with Trypanosoma cruzi-like strain RM1 were evaluated with regard to infection effectiveness, by means of microhematocrit.
After challenging with the Trypanosoma cruzi strains, the parasitemia was monitored in three animals from each group, for the whole patent period. During the subpatent period, blood cultures (LIT medium) were randomly performed on three animals in each group. Survival was monitored for 70 days and then the same animals that had been randomly selected for blood culturing were sacrificed by means of asphyxiation in an ether chamber. Tissue specimens from the liver, spleen, adrenal glands, heart, testicles, skeletal muscle, diaphragm, bladder, lymph nodes, esophagus and gastrointestinal junctions (esophagogastric, gastroduodenal and ileocecal) were collected, washed with saline and fixed in 10% buffered formalin solution for at least 48 hours. The tissue specimens were dehydrated in alcohol, diaphanized in xylene and embedded in paraffin. Following this, two sections of thickness 4-5 m from each of the tissue types from each mouse were stained using the hematoxylin-eosin technique (HE), with the aim of identifying parasitic nests and semiquantitatively classifying the tissue inflammatory processes as absent ( ), slight (+), moderate (++) or severe (+++) 21 34 . The parasitemia data were subjected to the Mann-Whitney nonparametric test or the Kruskal-Wallis test, followed by the post-hoc Dunn test, and the results were expressed as medians. Survival was evaluated by means of the Kaplan-Meier productlimit method and the Cox-Mantel test was applied. Furthermore, the final survival percentages were subjected to the chi-square test. Tissue parasitism and histopathological lesions among the groups were compared using the chi-square test. All analyses were performed using the Statistica software, version 7.0, and p-values < 0.05 were taken to be significant. The present work was approved by the Animal Use Ethics Committee of the Federal University of the Triângulo Mineiro (Protocol n o 48).
RESULTS
Trypanosoma cruzi-like strain RM1 did not demonstrate infectivity or pathogenicity towards mice, as shown by the negative results from of all microhematocrit and blood culturing tests and by the normal appearance of all muscle tissues evaluated. In lymphoid organs, there was a positive association between reactivity and number of inoculations with Trypanosoma cruzilike strain RM1. In the liver, diffuse inflammatory processes were observed, which damaged portal spaces and hepatic lobes in animals with three immunizations. However, there was no significant association between the number of inoculations and severity of hepatic lesions. Survival was similar among the non-challenged control groups, independently of the number of inoculations or presence of adjuvant, and reached more than 66.7%, depending on the treatment received by the group.
In the groups challenged with Trypanosoma cruzi strains, the prepatent period ranged from four to nine days. Among the mice infected with the JG strain, the patent period was longer than among those infected with the VIC strain.
The presence of adjuvant was a partial protective factor only when inoculated in association with Trypanosoma cruzi-like strain RM1, due to decreased parasitemia in the groups challenged with the JG strain. In animals challenged with the VIC strain, the pattern of the parasitemia curve was similar among the groups immunized with Trypanosoma cruzi-like strain RM1, in the presence or absence of adjuvant ( Figures 1A and 1B) . Evaluation of the effect of the adjuvant without any association showed that it prompted a partially negative factor, due to increased parasitemia in the groups challenged with the VIC strain. Among those infected with the JG strain, there were no differences between the groups not immunized with Trypanosoma cruzi-like strain RM1 that received only adjuvant and those that received saline ( Figures  1C and 1D) .
Regarding the number of inoculations with Trypanosoma cruzi-like strain RM1, there were no significant differences in the parasitemia curves among the groups with one, two or three inoculations. Nevertheless, it became clear that a single immunization was enough to observe decreased parasitemia in groups that received Trypanosoma cruzi-like strain RM1, in comparison with non-immunized groups ( Figures 1E and 1F ). Survival analysis on the challenged mice did not show any significant differences among the groups, and it reached more than 60%, depending on the immunization strategy, such as in the control groups.
The presence of amastigote nests was confirmed in infections with both Trypanosoma cruzi strains (VIC and JG), and there were no statistical differences between immunized and nonimmunized groups, regarding tissue parasitism. The JG strain showed greater infectivity than the VIC strain did, which was shown by the greater number of tissue types with the parasite and the rate of positive findings from histopathological examination. Nonetheless, in some tissues, the VIC strain presented greater severity of histopathological damage than the JG strain did.
With regard to the effects of Trypanosoma cruzi-like strain RM1 immunization in the histopathological lesions, there were no significant differences among the groups. However, in several tissue samples analyzed, the frequency and intensity of the inflammatory processes were higher in mice immunized with Trypanosoma cruzi-like strain RM1, independently of the number of inoculations and the Trypanosoma cruzi strain used for the challenge. In general, the pathological processes were focal or multifocal. Occasionally, they were diffuse, with variable intensity, and in some cases, they demonstrated muscle fiber destruction. The cellular infiltrates were observed to be characteristically mononuclear or polymorphonuclear, and one important discovery was the presence of severe eosinophilia, particularly in skeletal muscle (Figure 2) . Therefore, the intensity of tissue eosinophils was compared by taking into consideration the Trypanosoma cruzilike strain RM1 immunization and, likewise, the number of inoculations. Although the analysis showed that the difference was statistically nonsignificant, eosinophils were found to be more frequently present in immunized mice ( Figure 3A ), while they demonstrated higher intensity in those groups that received more than one inoculum of Trypanosoma cruzi-like strain RM1, when the number of immunizations was evaluated ( Figure 3B ). 
DISCUSSION
The search for vaccines against parasitic diseases is complex, for three main factors: difficulties in reproducing natural infection conditions in the laboratory, parasite survival strategies and the requirement for effective protection for the whole organism, observed either in the bloodstream or in tissue.
Some studies have reported decreased parasitemia reduction as a protection parameter against Trypanosoma cruzi infection 3 4 . Nevertheless, in several of them, there was no association with the histopathological analysis. Mice chronically infected for one year with Trypanosoma cruzi strain Y and challenged with this same strain presented decreased parasitemia 27 , regardless of whether total protection was shown. Similar cases tend to occur in studies using trypanosomatids strains isolated from other reservoirs, due to the high antigenic similarity between these isolates and Trypanosoma cruzi. In our findings, even though the immunological protection was suggested by the parasitemia levels, this effect was invalidated by the histopathological analysis.
Despite the non-induction of a sterile immune response, this and some other studies describing partial protection should not be discarded. The vector infection during blood meals from animals immunized with attenuated or inactivated strains and challenged against virulent strains was lower than in non-immunized animals 4 . These authors suggested that interference in the domestic cycle of Chagas disease possibly occurred via vaccination of animal reservoirs which are in contact with humans in endemic areas, such as dogs immunized with epimastigotes of Trypanosoma rangeli 6 . In order to induce effective protection from a vaccine, appropriate immune response activation is required. In Chagas disease, the main response involved in infection resistance is the T H 1-type immune reaction 23 . In this context, participation of adjuvants becomes important because of their ability to focus the immunological response to a cellular or humoral pattern that depends on the activated T-cell populations and the cytokine profile produced. In the present study, we used Freund's adjuvant, which can generate toxic effects in spite of its T H 1-type stimulating properties 33 , thereby leading to controversy relating to protection induction 20 .
One important point to be discussed regarding immunization against Trypanosoma cruzi concerns the pathogenic mechanisms during the chronic phase, such as parasite persistence and the role of autoimmunity 15 22 26 37 , which still remain unclear. Regarding parasite persistence, some authors believe that there is an association between increased parasitemia and the degree of lesions observed 22 37 , as demonstrated by blood and tissue PCR and immunohistochemistry 5 25 . In the present study, the JG strain was more infective than the VIC strain was, although the two strains presented similar pathogenicity. Furthermore, although the mouse immunization demonstrated decreased parasitemia, the severity of the lesions in those animals was higher than in the non-immunized animals. Further studies on Trypanosoma cruzispecific PCR and immunohistochemistry are needed in order to detect the presence of parasite DNA or antigens in tissue specimens from the animals studied. Indeed, the previous findings suggest that parasitemia observed during the acute phase may not always be associated with the degree of lesions during the chronic phase, which suggests an autoimmune mechanism 15 19 .
Prior to searching for a vaccine that confers total protection, knowledge of the immune response against Trypanosoma cruzi and how the immunoregulatory mechanisms drive the parasite infection is essential. Kierszenbaum 24 queried the autoimmune component in Chagas disease because of the great delay in producing tissue lesions (as much as decades after infection), in comparison with other immunological diseases in which autoreactive T cells and autoantibodies are responsible for sudden progression lesions. Thus, the presence of eosinophils in inflammatory heart infiltrates has been correlated with the severity of human chronic Chagas myocarditis 29 30 , suggesting possible pathogenic mechanisms other than the autoimmune component, defined by a substantial imbalance in the immunological system. In the present study, we noticed high numbers of eosinophils in tissue lesions, particularly in skeletal muscles. With regard to the immunized mice, there was a positive association between the number of Trypanosoma cruzi-like strain RM1 inoculations and eosinophilia intensity. These findings suggest that the number of cells present in histopathological lesions and the cell population type can be considered to be parameters for evaluating infection severity in the tissue 30 and the prognosis for Chagas disease patients.
Because of increased presence of eosinophils in inflammatory infiltrates caused by the number of immunizations, and the possible relationship between these cells and the intensity of tissue lesions, the effect of reinfection in Chagas disease cases needs to be discussed. Animals reinfected with Trypanosoma cruzi strains presented greater electrocardiographic abnormalities than did those infected just once 11 . In addition, a study using three Trypanosoma cruzi strains of different biodemes demonstrated greater histopathological damage in triple infected mice, which was not accompanied by exacerbated parasitemia or tissue parasitism 1 . A similar phenomenon was described in the present study using the Trypanosoma cruzi-like strain RM1 isolated from bats.
In endemic areas, people are subject to several reinfections during their lives. If this process is responsible for increased morbidity in Chagas disease cases, the ideas of continuous vector control, screening of blood donors and improvement of local housing 16 are reinforced and the effectiveness of a vaccine from attenuated or inactivated Trypanosoma cruzi strains becomes a controversial factor. Therefore, the development of protection against Chagas disease presents several issues. Research using trypanosomatids isolated from animal reservoirs is important for clarifying the virulence and pathogenicity factors of the disease and for use as a model in immunological and biochemical studies on Trypanosoma cruzi. After induction of partial protection via previous inoculation with these trypanosomatids, characterization of enzymes and surface antigens is needed in order to reveal new targets for vaccines.
Although immunization against Trypanosoma cruzi is unlikely to provide efficient sterile immunity 17 , the decreased parasitemia associated with accurate immunomodulation could be effective in reducing the extent of tissue lesions, thereby avoiding chronic progression of Chagas disease and mortality.
